Ontology highlight
ABSTRACT: Background
Rates of clinically elevated depressive symptoms among ambulatory oncology patients are higher than in the general population and are associated with poorer health-related quality of life. Furthermore, a reduction in depressive symptoms may be associated with improved cancer survival. Several interventions have demonstrated efficacy in reducing oncologic depressive symptoms, including cognitive-behavioral stress management (CBSM). However, more work is needed to understand how to best implement CBSM into practice, such as through stepped-care approaches and digital health interventions linked to electronic health records (EHR). This manuscript presents the protocol of the My Well-Being Guide study, a pragmatic type 1 effectiveness-implementation hybrid study. This trial will test the effectiveness of My Well-Being Guide, a seven-week structured, CBSM-based digital health intervention designed to reduce depressive symptoms. This trial will also evaluate My Well-Being Guide's implementation across two health systems.Methods
The final sample (N = 4561) will be oncology patients at Northwestern Medicine or University of Miami Health System who are ≥18 years of age; have a cancer diagnosis; elevated depressive symptoms on the Patient-Reported Outcomes Measurement Information System Depression; and primary language is English or Spanish. Data collection will occur at baseline, and 2-, 6-, and 12-months post baseline. Outcome domains include depressive symptoms and implementation evaluation.Discussion
This study may provide valuable data on the effectiveness of our depressive symptom management digital health intervention linked to the EHR and the scalability of digital health interventions in general.
SUBMITTER: Yanez B
PROVIDER: S-EPMC10846504 | biostudies-literature | 2023 Apr
REPOSITORIES: biostudies-literature
Yanez Betina B Czech Katherine A KA Buitrago Diana D Smith Justin D JD Schueller Stephen M SM Taub Chloe J CJ Kircher Sheetal S Garcia Sofia F SF Bass Michael M Mercer Ambrosine M AM Silvera Carlos A CA Scholtens Denise D Peipert John Devin JD Psihogios Alexandra M AM Duffecy Jennifer J Cella David D Antoni Michael H MH Penedo Frank J FJ
Contemporary clinical trials 20230217
<h4>Background</h4>Rates of clinically elevated depressive symptoms among ambulatory oncology patients are higher than in the general population and are associated with poorer health-related quality of life. Furthermore, a reduction in depressive symptoms may be associated with improved cancer survival. Several interventions have demonstrated efficacy in reducing oncologic depressive symptoms, including cognitive-behavioral stress management (CBSM). However, more work is needed to understand how ...[more]